Sandoz

Amgen cannot stop imminent sale of Neupogen copycat: US appeals court
Yahoo/Reuters
Wed, 09/2/15 - 12:37 pm
Amgen
Neupogen
biosimilars
Zarxio
Novartis
Sandoz
Amgen: Waiting for Clarity on Generic Biotech
Barron's
Fri, 08/21/15 - 11:05 am
Amgen
generics
biosimilars
Novartis
Sandoz
Neupogen
Zarxio
AbbVie And Amgen Threatened By Biosimilars
Bidness, ETC
Mon, 08/17/15 - 07:57 am
AbbVie
Amgen
biosimilars
JNJ
Sandoz
Novartis
Humira
Neupogen
Remicade
Nuelasta
Enbrel
epoetin-alfa
Why Sandoz Revenues Were Important for Novartis in 2Q15
Yahoo/Market Realist
Wed, 07/29/15 - 12:43 pm
Novartis
Sandoz
generics
earnings
Sandoz closing three German and Indian factories
BioPharma Dive
Tue, 07/28/15 - 10:14 am
Sandoz
Novartis
generics
Germany
India
Novartis whacks 3 Sandoz plants, 770 jobs, despite generic units' sales growth
Fierce Pharma
Thu, 07/23/15 - 11:30 pm
Novartis
Sandoz
generics
drug manufacturing
Novartis blocked from selling Neupogen copycat until Sept. 2
Yahoo/Reuters
Tue, 07/21/15 - 12:47 pm
Novartis
biosimilars
Neupogen
Zarxio
Sandoz
Amgen
Novartis off to scorching start with Copaxone generic Glatopa
Fierce Pharma Marketing
Mon, 07/13/15 - 11:11 am
Novartis
Copaxone
generics
Glatopa
MS
multiple scleroiss
Momenta
Sandoz
It's Teva vs. Momenta/Sandoz for Copaxone patients, with Mylan's version MIA
Fierce Pharma Marketing
Mon, 06/22/15 - 10:52 am
Teva Pharmaceutical
Momenta
Sandoz
generics
Novartis
Copaxone
MS
multiple sclerosis
U.S. court nixes Teva's Copaxone patent--again
Fierce Pharma
Thu, 06/18/15 - 04:00 pm
Copaxone
patents
Teva Pharmaceuticals
generics
Momenta
Novartis
Sandoz
Novartis tries to get U.S. ban lifted on sale of Neupogen copycat
Yahoo/Reuters
Wed, 06/3/15 - 07:37 pm
Novartis
Neupogen
biosimilars
Zarxio
Amgen
Sandoz
Amgen motion to delay Neupogen biosimilar denied
Medical Marketing and Media
Fri, 04/17/15 - 08:44 am
Amgen
Neupogen
biosimilars
Zarxio
Novartis
Sandoz
Denied Again! Another Obstacle to Biosimilar First Launch Falls with FDA Rejection of Amgen’s Certification Petition
FDA Law Blog
Fri, 03/27/15 - 08:39 am
Amgen
biosimilars
FDA
Sandoz
Neupogen
Zarxio
U.S. judge rejects Amgen injunction bid against Novartis Sandoz unit
Yahoo/Reuters
Fri, 03/20/15 - 11:00 am
Amgen
Neupogen
Novartis
Sandoz
biosimilars
Novartis Pays $12.6M Fine for Giving Inaccurate Pricing Data to Medicare
WSJ Pharmalot
Mon, 03/16/15 - 03:00 pm
Novartis
Sandoz
Medicare
Novartis wins approval for first U.S. biosimilar drug
Yahoo/Reuters
Fri, 03/6/15 - 10:01 am
Novartis
FDA
Neupogen
Zarxio
Sandoz
Amgen
Sandoz gets ready to make the biosimilar case with oncologists
Medical Marketing and Media
Thu, 01/22/15 - 09:51 am
Sandoz
biosimilars
physicians
oncologists
Neupogen
Zarxio
Novartis
Drug companies find common ground over Colorado's 'biosimilars' legislation
Bizjournals.com
Wed, 01/21/15 - 09:42 am
Colorado
biologics
generics
Amgen
Sandoz
FDA panel recommends approval for first generic biotech drug
Marketwatch
Wed, 01/7/15 - 06:49 pm
FDA
advisory panels
biosimilars
Neupogen
Amgen
Novartis
Sandoz
Novartis copy of Amgen biotech drug shows similar efficacy-study
Yahoo/Reuters
Mon, 12/8/14 - 08:24 am
Novartis
Amgen
Neupogen
biosimilars
Sandoz
neutropenia

Pages